HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types
Microorganisms · 21.07.2025 · 13 (7) · 1705
DOI: 10.3390/microorganisms13071705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 21.07.2025. Verfasst von Haruka Onodera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Kirin Holdings Co., Ltd., 2-26-1-12-12 Muraoka-Higashi, Fujisawa 251-8555, Japan. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human milk oligosaccharides (HMOs) have garnered significant attention as one of the bioactive components in human milk, with growing applications in infant formula and food products. HMOs enhance butyrate production, which is produced by butyrate-producing bacteria such as Faecalibacterium prausnitzii and contributes to gut health through its diverse biological functions. However, the specific mechanisms by which individual HMOs promote butyrate production remain unclear. In this study, we conducted in vitro co-culture experiments of F. prausnitzii and Bifidobacterium bifidum, examining their relative abundance, fatty acid production, residual sugar levels, and gene expression. Our results revealed that B. bifidum utilizes HMOs and provides the constituent sugars to F. prausnitzii, thereby promoting butyrate production by F. prausnitzii. Furthermore, we found that the underlying mechanisms vary depending on the structure of the HMOs. Specifically, 2′-fucosyllactose and 3′-sialyllactose enhance the butyrate production efficiency of F. prausnitzii, while 6′-sialyllactose primarily promotes the growth of F. prausnitzii. These findings not only deepen our understanding of how HMOs influence infant gut health but also suggest new directions for developing nutritional products that leverage the distinct functional properties of each HMO.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health Sciences, Kirin Holdings Co., Ltd., 2-26-1-12-12 Muraoka-Higashi, Fujisawa 251-8555, Japan.
- Kirin Central Research Institute, Kirin Holdings Co., Ltd., 2-26-1-12-12 Muraoka-Higashi, Fujisawa 251-8555, Japan.
ORCID-Profile: Haruka Onodera, Yohei Sato, Yosuke Komatsu, Makoto Yamashita, Yuta Watanabe, Takeshi Kokubo
Zitieren
APA
Onodera, H., Sato, Y., Komatsu, Y., Yamashita, M., Watanabe, Y., & Kokubo, T. (2025). HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types. Microorganisms, 13(7), 1705. https://doi.org/10.3390/microorganisms13071705
Vancouver
Onodera H, Sato Y, Komatsu Y, Yamashita M, Watanabe Y, Kokubo T. HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types. Microorganisms. 2025;13(7):1705. doi:10.3390/microorganisms13071705
BibTeX
@article{Onodera2025,
author = {Onodera, Haruka and Sato, Yohei and Komatsu, Yosuke and Yamashita, Makoto and Watanabe, Yuta and Kokubo, Takeshi},
title = {HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {7},
pages = {1705},
doi = {10.3390/microorganisms13071705}
}
EUVIMED